A Systematic Literature Review of the Prognostic and Predictive Value of PIK3CA Mutations in HR+/HER2 Metastatic Breast Cancer

  • Lea E. Mollon
  • , Elizabeth J. Anderson
  • , Joni L. Dean
  • , Terri L. Warholak
  • , Ayal Aizer
  • , Emma A. Platt
  • , Derek H. Tang
  • , Lisa E. Davis

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)e232-e243
JournalClinical Breast Cancer
Volume20
Issue number3
DOIs
StatePublished - Jun 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Oncology
  • Cancer Research

Keywords

  • Antiestrogens
  • Biomarker
  • PI3K inhibitor
  • Precision medicine
  • Somatic mutations

Cite this